🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Heading to @IDWeek2022 this week? Looking for topics at the intersection of infections and drug use? I compiled a list of relevant abstracts 👇 DM me if I missed something! #IDWeek2022 #IDtwitter docs.google.com/spreadsheets/d…

Congrats to co-fellow and rockstar @CarlosSaldanaMD on his important work on HIV molecular clusters among Hispanic/Latino gay or bisexual men in Atlanta and ways to improve HIV care in this population. 🤩

We had the best dinner with the best company at the Emory Fellows Dinner @IDWeek2022. Thank you Carlos del Rio & Dr. Farley. We truly have the best ID Division. @Armstrws @EmoryInfectDis @DocWoc71 @DocWoc71 @DavidHollandMD @vcantosl Colleen Kelley @sujitsuchindran Nadine Rouphael

An IDWeek highlight— getting to finally meet and chat with these leaders in ID/addiction! 🤩🤩 Shall we advocate for an ID/addiction session at @IDWeek2022 next year?

A pleasure to work w rising stars like Wendy Fujita. Wendy is working to end disparities in HIV & addiction in the DeepSouth; she’s part of a growing # of early career ID docs invested in #SUD & we need her help 👏🏻 ❤️‍🩹 Emory CFAR @EmoryInfectDis @CarlosSaldanaMD Jonathan Colasanti

We finally made it happen: a Wendy^2 + Carlos^2 photo. 🤩 @CarlosSaldanaMD and I are so lucky to train at @EmoryInfectDis with mentors and leaders like @Armstrws and Carlos del Rio. 😊

We achieved a new PR: largest transplant ID consult team! Had a great 2 weeks with Varun Phadke MD and our fabulous, Twitter-less APPs, resident, and fellows! 😁

We found that < 3% of ID physicians are waivered to Rx buprenorphine in the US. Other than eliminating the waiver itself (large barrier), what can we do to increase # of ID physicians who can treat OUD? Andrea Carter Jonathan Colasanti @SophiaHussen1 Anandi Sheth

It’s official! DEA announced X-waiver no longer required to treat patients with OUD with buprenorphine! 👏🏻👏🏻👏🏻

Thanks to NEJM Evidence for the chance to share our framework on the risks of IDU and opportunities to mitigate harm. A privilege to work with and learn from Katherine Rich, the engine and the brains behind this operation. The future of ID/addiction medicine is bright. 👇

.thuy bui & colleagues recommend the following applications as highest yield for inclusion in a point-of-care ultrasound curriculum for #InternalMedicine practitioners within #LowMiddleIncomeCountries: finding fluid & assessment of gross LV function. 📄 ow.ly/CEXN50Nijun

The @EmoryInfectDis fellows do Spring! Piedmont Park Wassim Abdallah @SamCO_MD Wendy Fujita Christina Mallarino Haeger Eli Wilber MD

This is HUGE!!!! #naloxone is NOW over the counter OTC!! Soo many considerations: Will it be available in areas where racial and ethnic minoritized people live? Will naloxone be affordable? Will health savings accounts cover the cost of this medication? AND today we CELEBRATE

A WikiGuidelines Consensus Statement: For adults with infective endocarditis, oral transitional therapy was at least as effective as IV-only therapy. ja.ma/3OAfjOr Emily McDonald Todd C. Lee